Belfort Junior, Rubens; Paula, Jayter Silva 
; Silva, Marcelo Jordão Lopes; Della Paolera, Mauricio; Kim, Thomas; Chen, Michelle Y.; Goodkin, Margot L.
Source: Clinical Therapeutics. Unidade: FMRP
Subjects: GLAUCOMA, HIPERTENSÃO OCULAR, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELFORT JUNIOR, Rubens et al. Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil. Clinical Therapeutics, v. 42, n. 2, p. 263-275, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2019.12.008. Acesso em: 01 jun. 2024.APA
Belfort Junior, R., Paula, J. S., Silva, M. J. L., Della Paolera, M., Kim, T., Chen, M. Y., & Goodkin, M. L. (2020). Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil. Clinical Therapeutics, 42( 2), 263-275. doi:10.1016/j.clinthera.2019.12.008NLM
Belfort Junior R, Paula JS, Silva MJL, Della Paolera M, Kim T, Chen MY, Goodkin ML. Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil [Internet]. Clinical Therapeutics. 2020 ; 42( 2): 263-275.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.clinthera.2019.12.008Vancouver
Belfort Junior R, Paula JS, Silva MJL, Della Paolera M, Kim T, Chen MY, Goodkin ML. Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil [Internet]. Clinical Therapeutics. 2020 ; 42( 2): 263-275.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.clinthera.2019.12.008
